Product image of Lifog (Latanoprost) supplied by GNH India

Lifog

Active Ingredient:
Latanoprost
Origin:
EU

Lifog (Latanoprost)

Latanoprost, the active ingredient in Lifog, is a prostaglandin analog presented as eye drops for ocular use. It lowers intra‑ocular pressure and is indicated for the treatment of open‑angle glaucoma and ocular hypertension in adult patients.

GNH India supplies Lifog as a licensed, GDP‑compliant international pharmaceutical supplier, adhering to EU quality standards and serving hospitals, pharmacies, and clinics worldwide with reliable sourcing and regulatory support. Our global logistics network ensures timely delivery and compliance with local import requirements for each destination.

Manufacturer / TM Owner

Brill Pharma Unipessoal Lda.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Latanoprost is a prostaglandin analog used to lower intra‑ocular pressure in glaucoma and ocular hypertension.

  • Open-angle glaucoma: reduces intra‑ocular pressure to prevent progressive optic nerve damage.
  • Ocular hypertension: lowers pressure to reduce the risk of developing glaucoma.
  • Secondary open-angle glaucoma: improves outflow in cases related to other ocular conditions.
  • Pseudoexfoliative glaucoma: enhances uveoscleral outflow to control pressure.
  • Pigmentary glaucoma: assists in managing pressure elevations associated with pigment dispersion.

How It Works

  • Latanoprost binds to prostaglandin F‑type receptors in the ciliary muscle, activating a cascade that remodels the extracellular matrix and increases uveoscleral outflow of aqueous humor. This enhanced outflow reduces intra‑ocular pressure, helping to protect the optic nerve from glaucomatous damage.

Side Effects

Latanoprost may cause ocular and systemic reactions after administration.

Common Side Effects

  • Eye redness: mild conjunctival hyperemia.
  • Increased eyelash growth: longer, thicker lashes.
  • Iris pigmentation: gradual darkening of the iris.
  • Eye irritation: transient burning or stinging.
  • Blurred vision: temporary visual disturbance.
  • Foreign body sensation: feeling of grit in the eye.

Serious or Rare Side Effects

  • Severe allergic reaction: swelling, rash, or difficulty breathing.
  • Uveitis: inflammation of the uveal tract requiring medical attention.
  • Macular edema: fluid accumulation in the retina that may affect vision.
  • Vision loss: sudden decrease in visual acuity.
  • Ocular infection: signs of infection such as discharge or pain.

Precautions & Warnings

Before using Lifog, consider the following safety measures.

  • Monitor IOP: schedule regular intra‑ocular pressure measurements.
  • Avoid use in active ocular infection: postpone treatment until infection resolves.
  • Caution in history of uveitis: assess risk of inflammation recurrence.
  • Do not combine with other prostaglandin analog eye drops: may cause excessive pressure reduction.
  • Pregnancy and breastfeeding: safety not established; use only if benefits outweigh risks.
  • Store at room temperature: keep bottle in original packaging, protect from light and moisture.

Avoid Interactions

Lifog may interact with other ophthalmic agents; review the following.

Major Interactions (Avoid)

  • Concomitant prostaglandin analog eye drops: additive IOP lowering may cause hypotony.
  • Cycloplegic agents: can diminish latanoprost efficacy.
  • Ocular anesthetics: may increase corneal toxicity.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory eye drops: may heighten ocular inflammation.
  • Beta‑blocker eye drops: additive IOP reduction requires monitoring.
  • Systemic carbonic anhydrase inhibitors: monitor intra‑ocular pressure for excessive lowering.

Frequently Asked Questions

Lifog contains latanoprost, a prostaglandin analog indicated for the management of open‑angle glaucoma and ocular hypertension. By lowering intra‑ocular pressure, it helps to prevent optic nerve damage and preserve visual function in affected patients.

Latanoprost binds to prostaglandin F‑type receptors in the ciliary body, triggering remodeling of extracellular matrix proteins. This process increases uveoscleral outflow of aqueous humor, thereby reducing intra‑ocular pressure and mitigating the risk of glaucomatous damage.

The prescribing clinician determines the appropriate regimen. Typically, one drop of Lifog is instilled once daily in the affected eye(s), usually in the evening, but the exact dosing schedule should follow the prescriber’s instructions.

Safety data for latanoprost in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To request Lifog, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lifog belongs to the prostaglandin analog class, which generally offers once‑daily dosing and strong IOP‑lowering efficacy. Compared with beta‑blocker eye drops such as timolol, prostaglandin analogs often have a more favorable dosing schedule and may be better tolerated, though individual response varies.

Store Lifog at room temperature, preferably below 25 °C. Keep the bottle tightly closed, protect it from light and moisture, and retain it in the original packaging until use. Do not freeze the product.

Lifog is applied as a single drop into the conjunctival sac of the affected eye(s). Tilt the head back, pull down the lower eyelid to form a pocket, place the drop without touching the eye, and close the eye gently for a few minutes to allow absorption.

Serious adverse events, although rare, include severe allergic reactions, uveitis, macular edema, sudden vision loss, and ocular infections. Patients should seek immediate medical attention if they experience significant eye pain, redness, swelling, or any sudden change in vision.

Lifog should be avoided in individuals with known hypersensitivity to latanoprost or any component of the formulation, and in patients with active ocular infections or inflammation. Caution is also advised for those with a history of uveitis or severe ocular surface disease.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Latanoprost

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT